Identification of a novel fibronectin-aggrecan complex in the synovial fluid of knees with painful meniscal injury

Journal of Bone and Joint Surgery

Volumn 93, Issue 4, 2011, Pages 336-340

  Scuderi, Gaetano J ^a   Golish, S Raymond ^a   Cook, Frank F ^b   Cuellar, Jason M ^c   Bowser, Robert P ^d   Hanna, Lewis S ^e  

^a STANFORD UNIVERSITY   (United States)

^b Group   (United States)

^c NYU HOSPITAL FOR JOINT DISEASES   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Cytonics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; FIBRONECTIN;

ACCURACY; ADULT; ARTHROSCOPIC SURGERY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JOINT ASPIRATION; KNEE INJURY; KNEE MENISCUS RUPTURE; KNEE PAIN; MALE; MENISCECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL DENSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTERACTION; SYNOVIAL FLUID;

EID: 79951863605     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.J.00718     Document Type: Article

References (34)

1. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213:626-34.
2. Cuellar JM, Scuderi GJ, Cuellar VG, Golish SR, Yeomans DC. Diagnostic utility of cytokine biomarkers in the evaluation of acute knee pain. J Bone Joint Surg Am. 2009;91:2313-20.
3. Homandberg GA, Hui F, Wen C, Purple C, Bewsey K, Koepp H, Huch K, Harris A. Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J. 1997;321(Pt 3):751-7. (Pubitemid 27084885)
4. Homandberg GA, Davis G, Maniglia C, Shrikhande A. Cartilage chondrolysis by fibronectin fragments causes cleavage of aggrecan at the same site as found in osteoarthritic cartilage. Osteoarthritis Cartilage. 1997;5:450-3. (Pubitemid 27522764)
5. Struglics A, Larsson S, Hansson M, Lohmander LS. Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases. Osteoarthritis Cartilage. 2009;17:497-506.
6. Scuderi GJ, Woolf N, Dent K, Golish SR, Cuellar JM, Cuellar VG, Yeomans DC, Carragee EJ, Angst MS, Bowser R, Hanna LS. Identification of a complex between fibronectin and aggrecan G3 domain in synovial fluid of patients with painful meniscal pathology. Clin Biochem. 2010;43:808-14.
7. Potts JR, Campbell ID. Structure and function of fibronectin modules. Matrix Biol. 1996;15:313-21. (Pubitemid 26419876)
8. Homandberg GA, Wen C, Hui F. Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage. 1998;6:231-44. (Pubitemid 28341737)
9. Anderson DG, Li X, Balian G. A fibronectin fragment alters the metabolism by rabbit intervertebral disc cells in vitro. Spine (Phila Pa 1976). 2005;30:1242-6.
10. Ding L, Guo D, Homandberg GA. The cartilage chondrolytic mechanism of fi- bronectin fragments involves MAP kinases: comparison of three fragments and native fibronectin. Osteoarthritis Cartilage. 2008;16:1253-62.
11. Yasuda T. Cartilage destruction by matrix degradation products. Mod Rheumatol. 2006;16:197-205. (Pubitemid 44227338)
12. Watanabe H, Yamada Y, Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J Biochem. 1998;124:687-93. (Pubitemid 28488144)
13. Bondeson J, Wainwright S, Hughes C, Caterson B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin Exp Rheumatol. 2008;26:139-45. (Pubitemid 351385270)
14. Struglics A, Larsson S. A comparison of different purification methods of aggrecan fragments from human articular cartilage and synovial fluid. Matrix Biol. 2010;29:74-83.
15. Lohmander LS, Ionescu M, Jugessur H, Poole AR. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum. 1999;42:534-44. (Pubitemid 29136102)
16. Larsson S, Lohmander LS, Struglics A. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study. Arthritis Res Ther. 2009;11:R92.
17. Dudhia J, Davidson CM, Wells TM, Vynios DH, Hardingham TE, Bayliss MT. Agerelated changes in the content of the C-terminal region of aggrecan in human articular cartilage. Biochem J. 1996;313(Pt 3):933-40.
18. Luo W, Guo C, Zheng J, Chen TL, Wang PY, Vertel BM, Tanzer ML. Aggrecan from start to finish. J Bone Miner Metab. 2000;18:51-6. (Pubitemid 30133660)
19. Lundell A, Olin AI, Mörgelin M, al-Karadaghi S, Aspberg A, Logan DT. Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure. 2004;12:1495-506.
20. Mont MA. Commentary & perspective on diagnostic utility of cytokine biomarkers in the evaluation of acute knee pain (2009;91:2313-20). 2009 Oct. http://www.ejbjs.org/Comments/2009/cp-oct09-mont.dtl. Accessed 2009 Dec 29.
21. Felson DT, Lohmander LS. Whither osteoarthritis biomarkers? Osteoarthritis Cartilage. 2009;17:419-22.
22. Rousseau JC, Delmas PD. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol. 2007;3:346-56. (Pubitemid 46864889)
23. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB; Osteoarthritis Biomarkers Network. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006;14:723-7.
24. Englund M, Guermazi A, Lohmander LS. The meniscus in knee osteoarthritis. Rheum Dis Clin North Am. 2009;35:579-90.
25. Golish SR, Diduch DR. Arthroscopic debridement of the arthritic knee: is there still a role? In: Brown TE, Cui Q, Mihalko WM, Saleh K, editors. Arthritis & arthroplasty: the knee. Philadelphia: Saunders Elsevier; 2009. p. 2-8.
26. Dearing J, Nutton RW. Evidence based factors influencing outcome of arthroscopy in osteoarthritis of the knee. Knee. 2008;15:159-63.
27. Siparsky P, Ryzewicz M, Peterson B, Bartz R. Arthroscopic treatment of osteoarthritis of the knee: are there any evidence-based indications? Clin Orthop Relat Res. 2007;455:107-12.
28. Stuart MJ, Lubowitz JH. What, if any, are the indications for arthroscopic debridement of the osteoarthritic knee? Arthroscopy. 2006;22:238-9.
29. Poehling GG. Degenerative arthritis arthroscopy and research. Arthroscopy. 2002;18:683-7.
30. Dervin GF, Stiell IG, Rody K, Grabowski J. Effect of arthroscopic débridement for osteoarthritis of the knee on health-related quality of life. J Bone Joint Surg Am. 2003;85:10-9. (Pubitemid 36537967)
31. Aaron RK, Skolnick AH, Reinert SE, Ciombor DM. Arthroscopic débridement for osteoarthritis of the knee. J Bone Joint Surg Am. 2006;88:936-43.
32. Spahn G, Mückley T, Kahl E, Hofmann GO. Factors affecting the outcome of arthroscopy in medial-compartment osteoarthritis of the knee. Arthroscopy. 2006;22:1233-40. (Pubitemid 44648673)
33. Kirkley A, Birmingham TB, Litchfield RB, Giffin JR, Willits KR, Wong CJ, Feagan BG, Donner A, Griffin SH, D'Ascanio LM, Pope JE, Fowler PJ. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2008;359:1097-107.
34. Howell JR, Handoll HH. WITHDRAWN: Surgical treatment for meniscal injuries of the knee in adults. Cochrane Database Syst Rev. 2009;1:CD001353.